What precautions should be taken when discharging a patient from the medical setting on new medication assisted therapy for alcohol use disorder?
This is based on the recent publication by Bernstein et al., PMID 38551564 which investigated the increased rate of initiation of MAUD in the hospital setting.
Answer from: at Academic Institution
Great question. This article absolutely adds to the argument for using medications for alcohol use disorder.
The precautions would mostly explain side effects, just as you would for any new medication. A few specific considerations depend on the medication (I'll restrict this to four more common ch...
Comments
at Baylor College of Medicine I would hope that some "standard labs" have been d...
Checking liver function before naltrexone and disulfiram and kidney function prior to acamprosate is important. Making sure the patient understands how the drugs work and consequences if contraindications are not observed. Advising about the administration of opiates is important for naltrexone. Obv...
Comments
at Mindpath Health Agree with Dr. @Rao and Dr. @Paul, very important ...
I strongly agree with the policy of having complete lab work before starting any of the AUD meds and ten ongoing monitoring of LFTs and kidney functions on outpatient basis.
Starting these medications on an inpatient basis is the best practice in a supervised environment and knowing that the patien...
I agree with the answers above but we should also be considering the potential use of GLP-1 medicines, for AUD especially if they are to be considered for other indications (Quddos et al., PMID 38017205 and Chuong et al., PMID 37192005).
I would hope that some "standard labs" have been d...